100 years of glucagon and 100 more
Wewer Albrechtsen, Nicolai J., Holst, Jens J., Cherrington, Alan D., Finan, Brian, Gluud, Lise Lotte, Dean, E. Danielle, Campbell, Jonathan E., Bloom, Stephen R. +3 more·2023·Diabetologia
Cited by (117)
Items 101–117 of 117
- Impact of obesity on aromatic amino acids and brain glucose during acute hyperglycemiaBrooke C. Matson, Felona Gunawan, Douglas L. Rothman, Graeme F. Mason, Olga Ilkayeva, Christopher B. Newgard, Janice Jin Hwang · 2026 · American Journal of Physiology-Endocrinology and Metabolism
- Insulin Resistance: Pathophysiology, Molecular Mechanisms, and Genetic InsightsHans‐Ulrich Häring, Baptist Gallwitz · 2026 · Elsevier eBooks
- Integrated glucagon model for estimation of α-cell responsivity to glucose and amino acids during graded glucose infusionFrancesca Sesillo Boscolo, Sneha Mohan, MARCELLO C. LAURENTI, Jacob D. Kohlenberg, Hannah E. Christie, Aoife Maria Egan, Adrian Vella, Chiara Dalla Man · 2026 · American Journal of Physiology-Endocrinology and Metabolism
- Hepatic HuR modulates glucose metabolism through the C/EBPβ/PCK1 pathwaySofía Lachiondo‐Ortega, Irene González‐Recio, Miren Bravo, María J. Gonzalez-Rellan, Arantza Sanz-Parra, Begoña Porteiro, Naroa Goikoetxea‐Usandizaga, Claudia M. Rejano-Gordillo, Leidy Estefanía Zapata-Pavas, Patricia Peña-Sanfélix et al. · 2026 · Molecular Metabolism
- Evolution of incretin-based therapies: From GLP-1 monotherapy to dual and triple agonists: A new era in metabolic therapyMonika Gupta, Jitendra Shukla · 2026 · The Indian Journal of Medical Research
- Dose–Response Effect of Glucagon on Glucose, Beta‐Cell Secretion and Metabolism in Healthy IndividualsSophie Betty Brock, Nina Lerberg Hansen, Elvar M. S. Jóhönnuson, Sasha A. S. Kjeldsen, Nicolai J. Wewer Albrechtsen · 2026 · Diabetes Obesity and Metabolism
- Hormonal Regulation of Protein Metabolism: Mechanisms and Clinical ImplicationsYves Boirie, Guillet Christelle · 2026 · Endocrinology
- α-cell SLC38A5 supports amino acid-induced α-cell proliferation and glucagon secretionKatelyn Sellick, Anna Marie R Schornack, Tyler J. Rodgers, Fedora O. Ogodo, Mounika P. Aramandla, Jade E. Stanley, Walter Siv, Matthew Shou, Nitin C. Shankar, Soham S. Saraf et al. · 2026 · Frontiers in Endocrinology
- Cagrilintide and retatrutide combination therapy enhances weight loss and metabolic outcomes in obese male ratsJonas Petersen, Christoffer Merrild, Stephanie Kjærulff Holm, Nigel Kurgan, Shad Hassan, Cecilie Vad Mathiesen, Stina Börchers, Charlotte Svendsen, Sebastiano D’Anna, Nicoline R. Andersen et al. · 2026 · Nature Metabolism
- Metabolic Reprogramming of the Liver by IL-33: A Protective Response to Acute InjuryYing Wu, Weinan Gao, Mengrui He, Wenda Zhang · 2026 · Cells
- Glucagon receptor deficiency is associated with glucocorticoid receptor activation and proteolytic remodeling in gastrocnemius of male miceXuanxuan Bai, Tongyu Zhang, Chao Zhang, Mingyu Li · 2026 · American Journal of Physiology-Endocrinology and Metabolism
- Digestive hormones and their impact on bariatric and pharmacologic weight-loss therapiesMaxime Amoyel, Claire Carette, Tigran Poghosyan, Johanne Le Beyec, Maude Le Gall · 2026 · Endocrine Reviews
- Survodutide for Obesity in Chinese Adults: Phase 3 Randomized Trial Design and Baseline Characteristics (SYNCHRONIZE™-CN)Linong Ji, Liming Chen, Zhifeng Cheng, Yibing Lu, Yan Yang, Fangming Fu, Yinan Zhu, Liying Jin, Isabel M. Kloer · 2026 · Diabetes Therapy
- For Weight Loss: Why Do GLP-1 Agonists Work, and How Can We Make Them Work Better?Charlise Giang, Jieyi Meng, Mahmoud Ali Mohammad, Zhenqi Liu, Xinle Wu, Yi Zhu · 2026 · Biology
- Early loss and progressive deterioration of glucagon responses to hypoglycemia in children with type 1 diabetesAntoine Harvengt, Maude Beckers, Ilektra Iakovidou, Anaïs Maure, Zain Syed, Laure Boutsen, Dominique Beckers, Philippe Antoine Lysy · 2026 · BMJ Open Diabetes Research & Care
- A Case of Mahvash Disease Caused by a Novel Homozygous Mutation in the Glucagon Receptor GeneRun Yu, Jessica E. Maxwell, Wai Chin Foo · 2026 · AACE Endocrinology and Diabetes
- The development of obesity pharmacotherapy: from early challenges and setbacks to recognition by WHOBruno Halpern, Louise A. Baur, Matthias Blüher, Angela Mary Jackson-Morris, Johanna Ralston, Donna Ryan · 2026 · The Lancet Diabetes & Endocrinology